Literature DB >> 17001749

Comparison of alternative methods of collection of service use data for the economic evaluation of health care interventions.

Sarah Byford1, Morven Leese, Martin Knapp, Helen Seivewright, Susan Cameron, Vanessa Jones, Kate Davidson, Peter Tyrer.   

Abstract

Economic evaluation of health care interventions usually requires the collection of service use data to estimate the total cost of participants in an evaluation. There are a number of methods available to measure the quantity of services used but little is known about the relative accuracy of alternative methods. In a multicentre randomised controlled trial of interventions for the treatment of adults with recurrent episodes of deliberate self-harm (the POPMACT trial), health service data were collected by patient self-report after six and twelve months and also from GP records by independent investigators. Agreement for overall costs was relatively high. However, this hides substantial variation in agreement between the two sources of information for different services. The results suggest that GP records provide more accurate data on the use of general practice-based contacts than patient report, but less reliable information on contacts with other health services. Thus reliance on GP records for data on hospital services and other community health services based outside of general practice surgeries is not recommended. Future research should explore the level of agreement between patient report and other providing sector records, such as hospital records. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17001749     DOI: 10.1002/hec.1175

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  25 in total

1.  Multiple sclerosis in the UK: service use, costs, quality of life and disability.

Authors:  Paul McCrone; Margaret Heslin; Martin Knapp; Paul Bull; Alan Thompson
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 2.  An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis.

Authors:  Matthew Franklin; James Lomas; Simon Walker; Tracey Young
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

3.  Measuring use of services for mental health problems in epidemiological surveys.

Authors:  Christine Sevilla-Dedieu; Viviane Kovess-Masfety; Matthias Angermeyer; Ronny Bruffaerts; Anna Fernandez; Giovanni De Girolamo; Ron De Graaf; Josep Maria Haro; Hans-Helmut König
Journal:  Int J Methods Psychiatr Res       Date:  2011-08-07       Impact factor: 4.035

4.  Impact of treatment success on health service use and cost in depression: longitudinal database analysis.

Authors:  Sarah Byford; Barbara Barrett; Nicolas Despiégel; Alan Wade
Journal:  Pharmacoeconomics       Date:  2011-02       Impact factor: 4.981

5.  Conservative treatment for uncomplicated appendicitis in children: the CONTRACT feasibility study, including feasibility RCT.

Authors:  Nigel J Hall; Frances C Sherratt; Simon Eaton; Isabel Reading; Erin Walker; Maria Chorozoglou; Lucy Beasant; Wendy Wood; Michael Stanton; Harriet J Corbett; Dean Rex; Natalie Hutchings; Elizabeth Dixon; Simon Grist; William Van't Hoff; Esther Crawley; Jane Blazeby; Bridget Young
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

6.  Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol.

Authors:  Christina Jerosch-Herold; Lee Shepstone; Edward C F Wilson; Tony Dyer; Julian Blake
Journal:  BMC Musculoskelet Disord       Date:  2014-02-07       Impact factor: 2.362

7.  Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial.

Authors:  Sadie Wickwar; Hayley McBain; Stanton P Newman; Shashivadan P Hirani; Catherine Hurt; Nicola Dunlop; Chris Flood; Daniel G Ezra
Journal:  Trials       Date:  2016-03-09       Impact factor: 2.279

8.  Comparisons of Costs between Black Caribbean and White British Patients with Advanced Multiple Sclerosis in the UK.

Authors:  Wayne Smith; Paul McCrone; Cassie Goddard; Wei Gao; Rachel Burman; Diana Jackson; Irene Higginson; Eli Silber; Jonathan Koffman
Journal:  Mult Scler Int       Date:  2014-02-05

9.  Cost-effectiveness of collaborative care for depression in UK primary care: economic evaluation of a randomised controlled trial (CADET).

Authors:  Colin Green; David A Richards; Jacqueline J Hill; Linda Gask; Karina Lovell; Carolyn Chew-Graham; Peter Bower; John Cape; Stephen Pilling; Ricardo Araya; David Kessler; J Martin Bland; Simon Gilbody; Glyn Lewis; Chris Manning; Adwoa Hughes-Morley; Michael Barkham
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

10.  Comparison of two methods of collecting healthcare usage data in chiropractic clinics: patient-report versus documentation in patient files.

Authors:  Taco Houweling; Jennifer Bolton; David Newell
Journal:  Chiropr Man Therap       Date:  2014-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.